Home  >  News
Eppen_Research3_6neo_Aug26
you can get e-magazine links on WhatsApp. Click here
News
  Acurx Pharma’s DNA Polymerase IIIC inhibitor antibiotics receives Japanese & Mexico patents,   August 14, 2026
  Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray,   August 07, 2026
  Resolve 360, secures patent to transform rehabilitation for neuromuscular and musculoskeletal disorders,   August 04, 2026
  Simparo earns fourth US patent, backed by Innovate Alabama Investment,   August 03, 2026
  ICMR transfers three indigenous biomedical technologies,   July 21, 2026
  Can-Fite BioPharma receives Australian Patent supporting Namodenoson development and marketing in liver and pancreatic cancer,   July 15, 2026
  Vyome receives Chinese patent covering formulation and therapeutic use claims relating to its proprietary besifloxacin topical gel programme for inflammatory acne,   July 03, 2026
  MindWalk seeks European patent for high-dimensional biological data architecture powering AI drug discovery,   July 03, 2026
  Universe Pharmaceuticals enters share purchase agreement to acquire Best Praise to expand pharma patent portfolio,   June 30, 2026
  CervoMed bags US Patent for use of neflamapimod in pure dementia with DLB,   June 19, 2026
  Nexalin Technology receives US patent covering dynamic frequency stimulation for anxiety, depression and insomnia,   June 08, 2026
  Pfizer INDovation programme supports 20 startups to propel India's next gen healthcare innovators,   June 04, 2026
  Travere Therapeutics receives notice of allowance from USPTO for patent of Biphenyl sulfonamide compounds to treat kidney diseases,   May 29, 2026
  Aphios Corporation receives USPTO’s notice of allowance for Bryoid compounds targeting Alzheimer’s disease, multiple sclerosis, HIV latency & cancer,   May 28, 2026
  Restart Life advances new product relaunch utilizing acquired intellectual property portfolio,   May 18, 2026
  ZYUS Life Sciences receives US patent entitled ‘Cannabichromene formulation for pain management’,   May 07, 2026
  Egetis Therapeutics’ MCT8 deficiency composition receives US patent,   May 06, 2026
  Pfizer reaches settlement agreements with Dexcel Pharma, Hikma Pharma & Cipla for infringement of patents relating to Vyndamax,   April 30, 2026
  OS Therapies submits patent application with US FDA covering biomarkers of immune response to Listeria monocytogenes,   April 18, 2026
  Model Medicines receives US patent related to MDL-001 in its broad antiviral Intellectual Property portfolio,   April 18, 2026

  • Results Found: 4579
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 229
 Back
 
analyticaLab_India2026
NPME-2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram